Skip to main navigation Skip to search Skip to main content

Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.

  • M Auer (Author)
  • G Bsteh (Author)
  • H Hegen (Author)
  • Wurth, S. (Author)
  • A Zinganell (Author)
  • T Berger (Author)
  • F Deisenhammer (Author)
  • F Di Pauli (Author)

Activity: Talk, presentation or poster › Poster

Period2020
Event title8th Joint Congress of the European Committee for Treatment and Research in Multiple Sclerosis and the Americas Committee for Treatment and Research in Multiple Sclerosis
Event typeConference
SponsorsEuropean Committee for Treatment and Research in Multiple Sclerosis, Americas Committee for Treatment and Research in Multiple Sclerosis
Degree of RecognitionInternational

Related content